Hansa's chief executive, Renée Aguiar-Lucander. The FDA has started a review of Hansa Biopharma's imlifidase for patients who need a kidney transplant, but for whom finding a donor is particularly ...
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Step One Clothing Limited (STP). However, you won't necessarily see their names in the ...
Hansa Biopharma AB focuses on novel immunomodulatory enzymes, which treat rare immunoglobulin G-mediated autoimmune conditions, transplant rejection and cancer. Its pipeline includes IdeS, HBP-assay, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results